![Simone Song](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Simone Song
Gründer bei
ORI Capital Investment Advisory Hong Kong Ltd.
Vermögen: - $ am 31.08.2026
Profil
Ms. Simone Song is a Founder & Senior Partner at ORI Capital Ltd. She is on the Board of Directors at Orchard Therapeutics (Europe) Ltd., Kymab Group Ltd. and Kymab Ltd.
Ms. Song was previously employed as an Independent Non-Executive Director by Orchard Therapeutics Plc, an Independent Director by CG Oncology, Inc., and a Managing Director by Cowen, Inc. She also served on the board at Trisalus Life Sciences, Inc. (United States).
She received her undergraduate degree from Fudan University and a graduate degree from Claremont Graduate University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CG ONCOLOGY, INC. -.--% | 05.06.2025 | 0 ( -.--% ) | - $ | 31.08.2026 |
Aktive Positionen von Simone Song
| Unternehmen | Position | Beginn |
|---|---|---|
ORI Capital Investment Advisory Hong Kong Ltd.
 ORI Capital Investment Advisory Hong Kong Ltd. Investment ManagersFinance ORI Capital invests in companies located across the globe. The firm targets companies operating in the fields of biotech with a focus on diagnostics, drug delivery, and therapeutics. It participates in early-stage transactions. | Gründer | 01.07.2015 |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Direktor/Vorstandsmitglied | - |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Direktor/Vorstandsmitglied | 22.12.2017 |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Direktor/Vorstandsmitglied | 20.01.2017 |
Ehemalige bekannte Positionen von Simone Song
| Unternehmen | Position | Ende |
|---|---|---|
| CG ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 22.11.2025 |
TriSalus Operating Life Sciences, Inc.
 TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for treatment of liver and pancreatic tumors | Direktor/Vorstandsmitglied | 01.01.2023 |
| COWEN INC. | Corporate Officer/Principal | - |
| ORCHARD THERAPEUTICS PLC | Direktor/Vorstandsmitglied | - |
Ausbildung von Simone Song
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
78
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Claremont Graduate University
 Claremont Graduate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fudan University
 Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cowen, Inc.
 Cowen, Inc. Investment Banks/BrokersFinance Provides corporate & investment banking and financial services | Finance |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Health Technology |
TriSalus Operating Life Sciences, Inc.
TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for treatment of liver and pancreatic tumors | Health Technology |
CG Oncology, Inc.
 CG Oncology, Inc. BiotechnologyHealth Technology Operates as a late-stage clinical biopharmaceutical company focused on developing and commercializing backbone bladder-sparing therapeutic | Health Technology |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Health Technology |
ORI Capital Investment Advisory Hong Kong Ltd.
ORI Capital Investment Advisory Hong Kong Ltd. Investment ManagersFinance ORI Capital invests in companies located across the globe. The firm targets companies operating in the fields of biotech with a focus on diagnostics, drug delivery, and therapeutics. It participates in early-stage transactions. | Finance |
Orchard Therapeutics Plc
 Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Health Technology |
